Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow International Ltd stock PB Ratio (=1.02) is close to 5-year high of 1.13.
The historical rank and industry rank for Pak Fah Yeow International's PB Ratio or its related term are showing as below:
HKSE:00239'
s PB Ratio Range Over the Past 10 Years
Min: 0.44 Med: 1.02 Max: 1.9
Current: 1
During the past 13 years, Pak Fah Yeow International's highest PB Ratio was 1.90. The lowest was 0.44. And the median was 1.02.
HKSE:00239's PB Ratio is ranked better than 75.6% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.915
vs HKSE:00239: 1.00
During the past 12 months, Pak Fah Yeow International's average Book Value Per Share Growth Rate was -1.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pak Fah Yeow International was 38.30% per year. The lowest was -19.50% per year. And the median was 6.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Pak Fah Yeow International PB Ratio Related Terms
Pak Fah Yeow International PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pak Fah Yeow International (HKSE:00239) has a PB Ratio of 1.00 as of Aug. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pak Fah Yeow International and its competitors. This is near median its historical median of 1.02. Over the past decade, Pak Fah Yeow International's PB Ratio has ranged from 0.44 to 1.90. According to the industry distribution chart, Pak Fah Yeow International ranks #225 out of 922 companies in the Drug Manufacturers industry, placing it in the top 24.4%.
Is Pak Fah Yeow International's PB Ratio too high?
Pak Fah Yeow International's current PB Ratio of 1.00 is near median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.90. The Drug Manufacturers industry median PB Ratio is 1.92. Pak Fah Yeow International's value of 1.00 is 47.8% below this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #225 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #225 out of 922 companies for PB Ratio. This places Pak Fah Yeow International in the top 24% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.92. Pak Fah Yeow International's value of 1.00 is 47.8% below this benchmark. Historically, Pak Fah Yeow International's own PB Ratio has ranged from 0.44 to 1.90 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 1.92, Pak Fah Yeow International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.92, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current PB Ratio of 1.00 is 47.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current PB Ratio is 1.00, which is near median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.32 — trading 6.7% above its estimated fair value. The current PB Ratio is 1.00, which is near median its 10-year median of 1.02 and 47.8% below the Drug Manufacturers industry median of 1.92. Pak Fah Yeow International's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current PB Ratio is 1.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.32 is trading 6.7% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
PB Ratio: 1.00 (near median its 10-year median of 1.02)
GF Value™: HK$2.17 vs. price of HK$2.32 (6.7% above fair value)
Industry Position: 47.8% below the Drug Manufacturers median (#225 of 922)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
